Ensuring Material Safety for Medical Devices and Biological Contact Applications

Biocompatibility testing is a fundamental part of medical device safety evaluation, focusing on how a material or finished product interacts with the human body. These studies are essential for determining whether a device can be safely used without causing harmful biological responses such as toxicity, irritation, or sensitization.

Our laboratory conducts biocompatibility assessments within a quality system aligned with OECD Good Laboratory Practice (GLP) principles when required, ensuring scientifically sound, traceable, and internationally accepted results.

Purpose of Biocompatibility Evaluation

The main objective of biocompatibility testing is to assess the biological response of living systems to materials that come into direct or indirect contact with the body. These evaluations are a regulatory requirement for medical device approval and help ensure patient safety throughout product use.

Key focus areas include:

• Assessment of cytotoxic effects
• Evaluation of irritation and sensitization potential
• Systemic toxicity screening
• Hemocompatibility considerations
• Material-tissue interaction analysis

ISO 10993 Framework

Biocompatibility studies are designed in accordance with the ISO 10993 series, which provides internationally recognized guidance for the biological evaluation of medical devices.

Depending on the device classification and contact type, testing strategies may include:

• Cytotoxicity testing (in vitro)
• Skin and mucosal irritation studies
• Sensitization assays
• Acute and subacute toxicity evaluations
• Material characterization and extract analysis

Study design is tailored based on device contact duration, exposure route, and clinical application.